Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect-Reference-Cited by-同舟云学术

Antihypertensive Effect of Long-Term Monotherapy with Esaxerenone in Patients with Essential Hypertension: Relationship Between Baseline Urinary Sodium Excretion and Its Antihypertensive Effect

Published:2022-08-17 Issue:10 Volume:39 Page:4779-4791
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Ichikawa Shuichi,Tsutsumi Junko,Sugimoto Kotaro,Yamakawa Satoru

Funder

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12325-022-02282-3.pdf

Reference37 articles.

1. Terker AS, Ellison DH. Renal mineralocorticoid receptor and electrolyte homeostasis. Am J Physiol Regul Integr Comp Physiol. 2015;309:R1068–70. https://doi.org/10.1152/ajpregu.00135.2015.

2. Esteras R, Perez-Gomez MV, Rodriguez-Osorio L, Ortiz A, Fernandez-Fernandez B. Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function. Ther Adv Drug Saf. 2015;6:166–76. https://doi.org/10.1177/2042098615589905.

3. Ando K, Fujita T. Pathophysiology of salt sensitivity hypertension. Ann Med. 2012;44(1 Suppl):S119–26. https://doi.org/10.3109/07853890.2012.671538.

4. Shibata S, Mu S, Kawarazaki H, et al. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest. 2011;121:3233–43. https://doi.org/10.1172/JCI43124.

5. Arai K, Tsuruoka H, Homma T. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats. Eur J Pharmacol. 2015;769:266–73. https://doi.org/10.1016/j.ejphar.2015.11.028.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of esaxerenone, a nonsteroidal mineralocorticoid receptor blocker, independent of urinary sodium/potassium ratio and salt intake;Hypertension Research;2024-01-25

2. Exploratory study on the relationship between urinary sodium/potassium ratio, salt intake, and the antihypertensive effect of esaxerenone: the ENaK Study;Hypertension Research;2024-01-11

3. Future treatments in hypertension: Can we meet the unmet needs of patients?;European Journal of Internal Medicine;2023-09

4. Biomarkers to Guide Medical Therapy in Primary Aldosteronism;Endocrine Reviews;2023-07-13

5. Recent progress in the diagnosis and treatment of primary aldosteronism;Hypertension Research;2023-05-17